anti-mesothelin T-cell engaging bispecific antibody JNJ-79032421
A bispecific T-cell engager (TCE) and bispecific antibody directed against both the tumor-associated antigen (TAA) mesothelin (MSLN) and the T-cell surface antigen CD3, with potential immunostimulating and antineoplastic activities. Upon administration, anti-mesothelin T-cell engaging bispecific antibody JNJ-79032421 targets and binds to MSLN expressed on tumor cells and to CD3 expressed on cytotoxic T lymphocytes (CTLs). This activates and redirects CTLs to MSLN-expressing tumor cells, which results in the CTL-mediated death of MSLN-expressing tumor cells. MSLN, a cell surface glycoprotein involved in cell adhesion, is overexpressed in a variety of cancer cell types.
Synonym: | anti-mesothelin/anti-CD3 bispecific antibody JNJ-79032421 anti-MSLN T-cell engager JNJ-79032421 anti-MSLN TCE JNJ-79032421 |
---|---|
Code name: | JNJ 2421 JNJ 79032421 JNJ-2421 JNJ-79032421 JNJ2421 JNJ79032421 |